/**/ RNS Number : 4541H Imaging Biometrics Limited 13 November 2025   Imaging Biometrics Limited (“IB” or the “Company”)   Imaging Biometrics’ Fractional Tumor Burden Mapping Enhances GBM Trial   A glioblastoma (GBM) clinical trial led by Dr. Danielle Bazer, DO, neuro-oncologist and Lead for Neuro-Oncology at MD Anderson Cancer Center at Cooper University, is…

Read more . . .

/**/ RNS Number : 9232G Imaging Biometrics Limited 10 November 2025   Imaging Biometrics, Ltd (the “Company”)   Imaging Biometrics Announces Successful Completion of Phase 1 Trial of Gallium Maltolate in Recurrent Glioblastoma   Imaging Biometrics, LLC, (“IB”), a leader in advanced quantitative imaging solutions, today announces the successful completion of its Phase 1 clinical…

Read more . . .

/**/ RNS Number : 5711D Imaging Biometrics Limited 16 October 2025   Imaging Biometrics Limited (“IBAI” or the “Company”) Further Re: Purchase of interest in Kirkstall Limited Imaging Biometrics Limited Limited (LSE: IBAI), provides an update following its announcement on 14 October 2025 regarding the purchase of the Company‘s interest in Kirkstall Limited (“Kirkstall”) from Truetide…

Read more . . .

/**/ RNS Number : 3286D Imaging Biometrics Limited 14 October 2025   Imaging Biometrics Limited (“IBAI” or the “Company”)   Purchase of Kirkstall Limited and CLN with Truetide plc – Correction   The following amendment has been made to the Purchase of Kirkstall Limited and CLN with Trueside plc announcement released on 14.10.25 at 7am.…

Read more . . .

/**/ RNS Number : 1881D Imaging Biometrics Limited 14 October 2025   14 October 2025   Imaging Biometrics Limited (“IBAI” or the “Company“)   Purchase of Kirkstall Limited and CLN with Truetide plc   Imaging Biometrics Limited (LSE: IBAI), is pleased to announce the purchase of 86.11% of the issued share capital of Kirkstall Limited…

Read more . . .